Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for aap Implantate AG's EV-to-EBIT or its related term are showing as below:
CHIX:AAQ1d'
s EV-to-EBIT Range Over the Past 10 Years
Min: -11.39 Med: -2.76 Max: -0.26
Current: -11.39
During the past 13 years, the highest EV-to-EBIT of aap Implantate AG was -0.26. The lowest was -11.39. And the median was -2.76.
CHIX:AAQ1d's EV-to-EBIT is ranked worse than 100% of 475
companies
in the Medical Devices & Instruments industry
Industry Median: 18.05
vs CHIX:AAQ1d: -11.39
aap Implantate AG (CHIX:AAQ1d) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
aap Implantate AG's Enterprise Value for the quarter that ended in Jun. 2026 was €49.74 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. aap Implantate AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was €-2.59 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
aap Implantate AG EV-to-EBIT Related Terms
aap Implantate AG EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for aap Implantate AG's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AAQ1D vs ABT, SYK, MDT: EV-to-EBIT Comparison
For the Medical Devices subindustry, aap Implantate AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aap Implantate AG EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where aap Implantate AG's EV-to-EBIT falls into.
aap Implantate AG's current Enterprise Value is €29.50 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. aap Implantate AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was €-2.59 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
aap Implantate AG (CHIX:AAQ1D) has a EV-to-EBIT of -11.39 as of Sep. 14, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on aap Implantate AG and its competitors. According to the industry distribution chart, aap Implantate AG ranks #999999 out of 475 companies in the Medical Devices & Instruments industry.
Is aap Implantate AG's EV-to-EBIT too high?
aap Implantate AG's current EV-to-EBIT is -11.39. Based on the distribution chart, aap Implantate AG ranks #999999 out of 475 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, aap Implantate AG has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does aap Implantate AG's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, aap Implantate AG ranks #999999 out of 475 companies for EV-to-EBIT. This places aap Implantate AG in the lower half of its industry. The industry median EV-to-EBIT is 18.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.05, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on aap Implantate AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aap Implantate AG's current EV-to-EBIT is -11.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aap Implantate AG stock overvalued right now?
aap Implantate AG (CHIX:AAQ1D) has a current EV-to-EBIT of -11.39. The stock's GF Value™ is €1.76, compared to a current price of €3.15 — trading 78.7% above its estimated fair value. The current EV-to-EBIT is -11.39. aap Implantate AG's overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For aap Implantate AG (CHIX:AAQ1D), the current EV-to-EBIT is -11.39 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aap Implantate AG (CHIX:AAQ1D) Overvalued in 2026?
Based on GuruFocus' analysis, aap Implantate AG stock appears to be overvalued.
The current stock price of €3.15 is trading 78.7% above its estimated GF Value™ of €1.76.
Key valuation signals for CHIX:AAQ1D:
EV-to-EBIT: -11.39
GF Value™: €1.76 vs. price of €3.15 (78.7% above fair value)
No single metric tells the full story. See the CHIX:AAQ1D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
43GF Score
Get the complete analysis for CHIX:AAQ1D
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AAQ1D has been successfully added to your 
